Research Topics
Species | Erling TronvikSummaryAffiliation: Norwegian University of Science and Technology Country: Norway Publications
| Collaborators
|
Detail Information
Publications
Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trialErling Tronvik
Department of Neurology and Clinical Neurophysiology, Norwegian University of Science and Technology, Trondheim, Norway
JAMA 289:65-9. 2003..There is a paucity of effective, well-tolerated drugs available for migraine prophylaxis...
Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patientsErling Tronvik
Department of Neurosciences, Norwegian University of Science and Technology, Trondheim, Norway
BMC Neurol 8:4. 2008..We also wanted to examine whether a clinical response to an ACE inhibitor, lisinopril, or an angiotensin II receptor blocker, candesartan, in migraine prophylaxis was related to ACE genotype...
New drugs for migraineLars Jacob Stovner
Norwegian National Headache Centre, Trondheim University Hospital, 7006 Trondheim, Norway
J Headache Pain 10:395-406. 2009....
Involvement of the renin-angiotensin system in migraineErling Tronvik
Norwegian National Headache Centre, Norwegian University of Science and Technology, Trondheim University Hospital, Trondheim, Norway
J Hypertens Suppl 24:S139-43. 2006..The RAS has several actions that may be relevant in migraine pathophysiology, but the reason for the prophylactic effect of ARBs/ACEIs in migraine remains a matter of speculation...
